Fluticasone Propionate and Formoterol Fumarate Inhaler|AIRFLOWMAX F250

Description

AIRFLOWMAX F250 is a highly effective combination inhaler containing Fluticasone Propionate and Formoterol Fumarate. This dual-action formulation is designed to provide comprehensive relief for patients suffering from asthma and chronic obstructive pulmonary disease (COPD). It helps in controlling inflammation and relaxing the airway muscles, ensuring easier breathing and long-term respiratory comfort. Composition: Each metered dose contains: Fluticasone Propionate Formoterol Fumarate Uses: Management of asthma and prevention of asthma symptoms such as wheezing, breathlessness, and chest tightness. Long-term maintenance treatment of COPD, including chronic bronchitis and emphysema. Helps reduce the frequency of flare-ups and improves overall lung function. Key Benefits: Dual therapeutic action: anti-inflammatory and bronchodilator effects. Provides long-lasting relief from breathing difficulty. Reduces airway inflammation and prevents asthma attacks. Improves overall respiratory performance and quality of life. Convenient inhalation form for direct lung delivery and faster onset of action. Mechanism of Action: Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, preventing asthma symptoms. Formoterol Fumarate is a long-acting bronchodilator that relaxes the smooth muscles of the airways, allowing better airflow and easier breathing. Together, they offer synergistic control over both the cause and symptoms of respiratory distress. Possible Side Effects: Throat irritation or hoarseness Cough or dry mouth Headache Mild tremors In rare cases, allergic reactions or palpitations Precautions: Use only as directed by your healthcare provider. Rinse your mouth after each use to prevent oral infections. Not recommended for sudden asthma attacks; use a rescue inhaler in such cases. Inform your doctor if you have any history of heart disease or thyroid disorder. Conclusion: AIRFLOWMAX F250 offers advanced, dual-action respiratory support for individuals suffering from asthma and COPD. By combining the anti-inflammatory power of Fluticasone Propionate with the bronchodilating efficacy of Formoterol Fumarate, it ensures improved breathing comfort, better lung health, and a higher quality of life.